What is included in the requirements of the Combat Methamphetamine Epidemic Act regarding purchasers of pseudoephedrine?

The requirements of the Combat Methamphetamine Epidemic Act specifically relate to the regulation of products containing pseudoephedrine, a common ingredient in decongestants that can be misused in the production of methamphetamine. One of the key aspects of this legislation is that purchasers must provide their name and address, which pharmacies must document and maintain for a period of two years. This record-keeping is essential for tracking the sales and limiting the potential for abuse of pseudoephedrine products.

The inclusion of the requirement to keep these records for a specified duration helps authorities monitor patterns of purchase that may indicate illegal activity, thereby helping to combat the methamphetamine epidemic. This approach focuses on accountability and traceability in the distribution of these medications.

Other options, such as obtaining a pharmacist's signature, verifying insurance coverage, or completing a training course are not mandates set forth by the Combat Methamphetamine Epidemic Act concerning the purchase of pseudoephedrine. Thus, maintaining accurate purchaser information is the primary focus of the correct answer.